Related Experiment Video
Updated: Aug 30, 2026

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS
Caterina Serra1, Giuseppe Mameli, Giannina Arru
1Section of Microbiology, Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Abstract:
Multiple sclerosis (MS)-associated retrovirus (MSRV) is a component of the human endogenous retrovirus (HERV)-W family, with gliotoxic and superantigenic properties, related to MS clinical progression, and transactivated by viral agents. The authors studied MSRV modulation by cytokines involved in vivo in MS course, utilizing peripheral blood mononuclear cells from MSRV-positive and MRSV-negative individuals. Cultured cells from MSRV-negative subjects did not produce virus, whereas spontaneous MSRV release was detected in cultures from MSRV-positive donors; virus release was increased by interleukin (IL)-4 and IL-6 and, to a greater extent, by the detrimental cytokines interferon gamma and tumor necrosis factor (TNF)alpha. Interferon beta, used in MS therapy, inhibits MSRV release. A parallel between the effects of these cytokines on MSRV production in vitro and on MS disease in vivo is observed, which deserves further elucidations.
Insights
Multiple sclerosis (MS)-associated retrovirus (MSRV) is modulated by cytokines. Pro-inflammatory cytokines increase MSRV release, while interferon beta (IFN-β) inhibits it, suggesting a therapeutic target for MS.
Area of Science:
- Immunology
- Neurovirology
- Retroviruses
Background:
- Multiple sclerosis (MS) is a chronic neurological disease.
- The human endogenous retrovirus (HERV)-W family includes MS-associated retrovirus (MSRV).
- MSRV exhibits gliotoxic and superantigenic properties and is linked to MS progression.
Purpose of the Study:
- To investigate the modulation of MSRV by cytokines relevant to MS.
- To analyze MSRV production in peripheral blood mononuclear cells (PBMCs) from MS patients.
Main Methods:
- Utilized PBMCs from MSRV-positive and MSRV-negative individuals.
- Cultured cells were exposed to various cytokines, including IL-4, IL-6, IFN-γ, TNF-α, and IFN-β.
- MSRV release was quantified in response to cytokine stimulation.
Main Results:
- MSRV was spontaneously released by cells from MSRV-positive donors but not MSRV-negative donors.
- Interleukin-4 (IL-4) and Interleukin-6 (IL-6) increased MSRV release.
- Interferon gamma (IFN-γ) and Tumor Necrosis Factor alpha (TNF-α) significantly enhanced MSRV production, while Interferon beta (IFN-β) inhibited it.
Conclusions:
- Cytokine profiles observed in vitro correlate with in vivo MS disease activity.
- IFN-β, an MS therapeutic, demonstrates inhibitory effects on MSRV release.
- These findings suggest a potential role for MSRV and its modulation in MS pathogenesis.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Mechanisms of Retrovirus-induced Cancers
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Retrovirus Life Cycles
